Commentary: Dietary Glutamic Acid, Obesity, and Depressive Symptoms in Patients With Schizophrenia

• Tauseef A. Khan,
• Tauseef A. Khan,
• Tauseef A. Khan,
• John L. Sievenpiper,
• John L. Sievenpiper,
• John L. Sievenpiper,
• John L. Sievenpiper,
• John L. Sievenpiper,
• John D. Fernstrom,
• John D. Fernstrom

Affiliations

Tauseef A. Khan

Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada

Tauseef A. Khan

Toronto 3D Knowledge Synthesis and Clinical Trials Unit, St. Michael's Hospital, Toronto, ON, Canada

Tauseef A. Khan

Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, ON, Canada

John L. Sievenpiper

Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada

John L. Sievenpiper

Toronto 3D Knowledge Synthesis and Clinical Trials Unit, St. Michael's Hospital, Toronto, ON, Canada

John L. Sievenpiper

Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, ON, Canada

John L. Sievenpiper

Division of Endocrinology & Metabolism, Department of Medicine, St. Michael's Hospital, Toronto, ON, Canada

John L. Sievenpiper

Scientist, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada

John D. Fernstrom

Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States

John D. Fernstrom

Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States